Evidence map›Paper›PMID 32713763›Full record

ArticleTrends in parasitology2021

Schistosoma mansoni.

Timothy J C Anderson, Egie E Enabulele

Abstract read
In one paragraph

Article in Trends in parasitology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Natural Compounds as Antimicrobial Agents-2nd Edition.Antibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Combined fluorescentBiology methods & protocols · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timothy J C AndersonTexas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: tanderso@txbiomed.org.
Egie E EnabuleleTexas Biomedical Research Institute, San Antonio, TX, USA.

Funding

Genetic Basis of Praziquantel ResistanceR01AI123434 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ANDERSON, TIM J, LOVERDE, PHILIP T · 2016 to 2020
$3.5M
Structure-guided redesign of an antischistosomal drugR01AI115691 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LOVERDE, PHILIP T · 2015 to 2019
$2.6M
Genetic analysis of cercarial release in schistosomesR01AI133749 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ANDERSON, TIM J · 2017 to 2021
$2.5M
NIAID NIH HHS R01 AI115691NIAID NIH HHS R01 AI123434NIAID NIH HHS R01 AI133749
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnthelminticsHumansLife Cycle StagesSchistosoma mansoniSchistosomiasis mansoniSnailsAnthelminticsepidemiologyneoblastspathologypraziquanteltrematode

Identifiers

PMID32713763
PMCPMC8101330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.